• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Med Virol . Are the original SARS-CoV-2 novel mutants from in vitro culture able to escape the immune response?

tetano

Editor, Senior Moderator
J Med Virol


. 2023 Jul;95(7):e28931.
doi: 10.1002/jmv.28931. Are the original SARS-CoV-2 novel mutants from in vitro culture able to escape the immune response?

Jun He[SUP] 1 2 3 [/SUP], Qingmin Mei[SUP] 1 4 [/SUP], Yousong Peng[SUP] 5 [/SUP], Jiajia Xie[SUP] 1 4 [/SUP], Weiwei Li[SUP] 1 2 3 [/SUP], Chengchao Ding[SUP] 1 4 [/SUP], Chengcheng Jiang[SUP] 1 4 [/SUP], Qingqing Chen[SUP] 1 2 3 [/SUP], Jing Wang[SUP] 1 4 [/SUP], Yuqing Zhang[SUP] 1 4 [/SUP], Shuangshuang Ni[SUP] 1 4 [/SUP], Junling Yu[SUP] 1 2 3 [/SUP], Tao Liu[SUP] 6 [/SUP], Weifei Yang[SUP] 6 [/SUP], Lei Gong[SUP] 2 3 [/SUP], Xiangyu Zhang[SUP] 1 4 [/SUP], Yuan Yuan[SUP] 2 3 [/SUP], Zhuhui Zhang[SUP] 2 3 [/SUP], Lan He[SUP] 2 3 [/SUP], Hongliang He[SUP] 1 4 [/SUP], Yong Sun[SUP] 1 2 3 [/SUP], Jiabing Wu[SUP] 1 2 3 [/SUP], Zhirong Liu[SUP] 1 2 3 [/SUP], Yong Gao[SUP] 1 4 [/SUP]



Affiliations
Abstract

Monitoring variations in the virus genome to understand the SARS-CoV-2 evolution and spread of the virus is extremely important. Seven early SARS-CoV-2 isolates in China were cultured in vitro and were analyzed for their viral infectivity through viral growth assay, tissue culture infectious dose (TCID[SUB]50[/SUB] ) assay, spike protein quantification, and next generation sequencing analysis, and the resultant mutations in spike protein were used to generate the corresponding pseudoviruses for analysis of immune escape from vaccination and postinfection immunity. The results revealed that in vitro cultured SARS-CoV-2 virus had much higher mutation frequency (up to ~20 times) than that in infected patients, suggesting that SARS-CoV-2 diversify under favorable conditions. Monitoring viral mutations is not only helpful for better understanding of virus evolution and virulence change, but also the key to prevent virus transmission and disease progression. Compared with the D614G reference strain, a pseudovirus strain of SARS-CoV-2 was constructed with a high mutation rate site on the spike protein. We found some novel spike mutations during in vitro culture, such as E868Q, conferred further immune escape ability.

Keywords: Genomic mutation; Immune escape ability; SARS-CoV-2.

 
Back
Top Bottom